Navigation Links
No Headway Against COPD, Which Now Affects Women More
Date:6/29/2011

onmental risk factors include exposure to toxic fumes at work. There is also a genetic component that can raise the risk, Akinbami said. In addition, the CDC report noted that diet and recurrent infections may play a role.

The CDC team also found strong ethnic and geographical disparities in COPD. For example, COPD was more common among Puerto Ricans and whites than among blacks and Mexican Americans.

COPD was also more common among adults living below the poverty level (8.3 percent) than among those whose income is at least 200 percent above the poverty level (4.3 percent).

And there were big differences region-to-region. The rate of COPD was almost twice as high in the East South Central states (7.5 percent) vs. the Pacific states (3.9 percent), according to the report.

COPD is a progressive and incurable disease. However, progress has been made in treating the symptoms of the disease, which can at least improve a patient's quality of life. This report found that the rate of hospitalizations for COPD fell among both men and women during the study period, the CDC noted. However, the death rate from COPD dropped only for men.

"Although you can't cure it once you have it, getting diagnosed early and receiving treatment can really help prevent a lot of the complications and ease the symptoms," Akinbami said.

Commenting on the report, Dr. E. Neil Schachter, a professor of pulmonary, critical care and sleep medicine at Mount Sinai School of Medicine and director of the Mount Sinai COPD Program in New York City, said that "this has been developing of the last 15 years -- that COPD is a major health hazard in the United States."

"COPD is the only growing disease among the major diseases that kill people," noted Schachter, who is also a professor of pediatrics and preventive medicine.

Right now, he said, doctors can only treat COPD symptoms -- mainly difficulties in breathing -- and there is no way to stop progression or reve
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. DU researchers find that headway being made fighting communicable diseases globally
2. Researchers Report Treatment Headway Against Lung Cancer
3. Living antibiotic effective against Salmonella
4. Cooling system may build eggs natural defenses against salmonella
5. Mystery ingredient in coffee boosts protection against Alzheimers disease
6. New stem cell research could aid in battle against bulging waistlines
7. Radionuclide treatment against small tumors and metastases
8. Has Chinas campaign against female feticide done more harm than good?
9. Breast-feeding May Shield Against Sudden Infant Death Syndrome
10. Cancer Drug Avastin Makes Inroads Against Ovarian Tumors
11. Intestinal cell defense mechanism against bacteria
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
No Headway Against COPD, Which Now Affects Women More
(Date:11/24/2014)... Longmont, CO, and Philadelphia, PA (PRWEB) November 24, ... a provider of care coordination and disease management ... organizations, has chosen to implement Essette’s Medical Management ... powerful new Essette SaaS platform in a program ... latest Essette suite includes Population Health Management, Care ...
(Date:11/24/2014)... 2014 "My friend was killed when ... cross the street in his motorized wheelchair," said an ... I came up with this idea so that people ... He developed the Safety Lites to make a wheelchair ... The device ensures that motorists can see the wheelchair. ...
(Date:11/23/2014)... For the coming special Friday, Tidebuy, a famous ... promotion for many products, especially the beautiful colored wedding ... choice with amazing discounts, up to 90% off. Don’t ... is easy to buy colored wedding dresses in different ... also famous for delicate craftsmanship, elegant style and perfect ...
(Date:11/23/2014)... November 23, 2014 Pro Ace Care, a ... it will now be providing an 8 year warranty on ... water tank installations went up due to the impending winter ... its customers of the premium service that the company provides. ... year warranty on John Wood and Bradford hot water tanks. ...
(Date:11/23/2014)... holidays can be a challenge for families of children ... an expert says. "Holidays with family can be ... have children with special needs, some care must be ... of the Sciences in Philadelphia, said in a university ... or visitors know what special requirements are needed to ...
Breaking Medicine News(10 mins):Health News:ReAdmission Solutions, LLC Selects Essette 2Health News:Beautiful Wedding Dresses Available at Popular B2C Company Tidebuy 2Health News:Pro Ace Care Now Gives 8 Year Guarantee on Selected Vancouver Hot Water Tanks 2Health News:Holidays Can Be Sensory Overload for Kids With Autism 2
... By Madonna Behen HealthDay Reporter , WEDNESDAY, Jan. ... killer in the world, and only about 15 percent of ... treatable. But two preliminary studies that are scheduled to ... scientists are moving closer to developing new screening tests that ...
... available in Spanish . , Let us assume ... GP is not sure what is wrong, and notes down on ... questions have been answered, the screen shows what the disease could ... to see such-and-such a specialist. Today this is utopia, but the ...
... lower risk of developing Type 2 diabetes, a disease on ... health problems? Scientists are offering a new solution to that ... Agricultural & Food Chemistry . Ling Zheng, Kun Huang ... are at a lower risk for developing Type 2 diabetes, ...
... fast-tracked through hospital emergency departments and operated on within ... developed by UK experts in anaesthesia, orthopaedics, geriatrics and ... Anaesthesia . However, patients in one ... longer than two days, risking lengthier inpatient stays, increased ...
... ,Surgeons aged 35 to 50 provide the safest care for ... about ongoing training and motivation of surgeons during their careers, ... France. They analyzed data from 3,574 thyroidectomies (removal of ... over a one-year period. The average age of the surgeons ...
... risks, but a new study shows that the consequences of ... function, according to a new study by University of Alabama ... of the Journal of the American Medical Association . ... in the United States, according to the National Survey on ...
Cached Medicine News:Health News:Tests Might Someday Help Spot Early Lung Cancer 2Health News:Tests Might Someday Help Spot Early Lung Cancer 3Health News:The keys to helping patients, on the GP's computer 2Health News:The keys to helping patients, on the GP's computer 3Health News:Hip fracture guidelines tackle 'considerable variations' in UK and Irish hospital care 2Health News:Hip fracture guidelines tackle 'considerable variations' in UK and Irish hospital care 3Health News:Surgeons in Mid-Career Have Fewest Complications: Study 2Health News:Marijuana smoke not as damaging to lungs as cigarette smoke 2Health News:Marijuana smoke not as damaging to lungs as cigarette smoke 3
(Date:11/24/2014)... SOUTH SAN FRANCISCO, Calif. , Nov. 24, 2014 /PRNewswire/ ... James M. Gower is retiring from the board ... executive officer, and Raul Rodriguez , most recently serving ... the position of chief executive officer and join the board ... Board of Directors since 2005, will become chairman. Mr. Gower ...
(Date:11/24/2014)... , Nov. 24, 2014  Inovio Pharmaceuticals, Inc. (NASDAQ: ... Joseph Kim , President and CEO of Inovio Pharmaceuticals, will ... team to ring the Nasdaq Opening Bell tomorrow, Tuesday November ... September 15 th listing on the Nasdaq Global Select ... Dr. Kim said, "We are honored to ring the Nasdaq ...
(Date:11/22/2014)...  Sprout Pharmaceuticals today announced positive preliminary results from a ... flibanserin up to 200 mg at bedtime had no next-day ... 20 th Annual Fall Scientific Meeting of the Sexual ... Miami . The Phase 1 ... Letter and the Formal Dispute Resolution that was filed in ...
Breaking Medicine Technology:Rigel Announces Executive Management Changes 2Rigel Announces Executive Management Changes 3Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market 2Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market 3Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 2Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 3
... Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) today ... 2) in gout patients initiating allopurinol therapy, ARCALYST (rilonacept) ... primary endpoint was the number of gout flares per ... ARCALYST at a weekly, self-administered, subcutaneous dose of either ...
... Feb. 28, 2011 Nile Therapeutics, Inc. (Nasdaq: ... development of novel therapeutics for cardiovascular disease, announced plans ... heart failure.  Nile plans to develop cenderitide (formerly CD-NP) ... decompensated heart failure (ADHF) patients continuously for up to ...
Cached Medicine Technology:ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 2ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 3ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 4ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 5ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 6ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 7ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 8ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 9ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 10Nile Therapeutics Announces Plans to Pursue a Post-Acute Indication in Heart Failure 2Nile Therapeutics Announces Plans to Pursue a Post-Acute Indication in Heart Failure 3Nile Therapeutics Announces Plans to Pursue a Post-Acute Indication in Heart Failure 4
The A350 test is used for POC testing in hospital emergency departments, replacing the need to draw blood for alcohol testing. Each hash mark is 0.02% or 20 mg/dL....
... Tests are available in 14 configurations including ... using Microgenics Antibody Technology, the SureStep™ MDMA ... care immunoassay targeted to detect MDMA that ... MDEA but no cross-reactivity to any isomer ...
... Drug Screen Tests are available in 14 ... (Ecstasy). Designed using Microgenics Antibody Technology, the ... point of care immunoassay targeted to detect ... MDA and MDEA but no cross-reactivity to ...
... SureStep™ Drug Screen Tests are available in ... MDMA (Ecstasy). Designed using Microgenics Antibody Technology, ... only point of care immunoassay targeted to ... both MDA and MDEA but no cross-reactivity ...
Medicine Products: